[Federal Register Volume 64, Number 94 (Monday, May 17, 1999)]
[Notices]
[Pages 26759-26761]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-12312]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 99123]
Notice of Availability of Funds; Grant for Community-Based
Intervention Research for Children Riding in Motor Vehicles
A. Purpose
The Centers for Disease Control and Prevention (CDC), announces the
availability of fiscal year (FY) 1999 funds for a grant to conduct a
Community-Based Intervention Program for Children Riding in Motor
Vehicles. The purpose of the program is to design, implement, and
evaluate a community-based intervention project aimed at changing the
seating locations and restraint-use patterns of children riding in
passenger cars and light trucks. The goal is to induce all children
under the age of 12 to be seated in the rear seat (if one exists) and
to be properly restrained in a safety seat or child restraint device.
This program addresses the ``Healthy People 2000'' priority area of
Unintentional Injuries.
[[Page 26760]]
B. Eligible Applicants
Applications may be submitted by public and private nonprofit
organizations and by governments and their agencies; that is,
universities, colleges, research institutions, hospitals, other public
and private nonprofit organizations, State and local governments or
their bona fide agents, and federally recognized Indian tribal
governments, Indian tribes, or Indian tribal organizations.
Note: Public Law 104-65 states that an organization described in
section 501(c)(4) of the Internal Revenue Code of 1986 which engages
in lobbying activities shall not be eligible to receive Federal
funds constituting an award, grant (cooperative agreement),
contract, loan, or any other form.
C. Availability of Funds
Approximately $250,000 is available in FY 1999 to fund one award.
It is expected that the award will begin on or about September 30,
1999, and will be made for a 12-month budget period within a project
period of up to 3 years. Funding estimates may change.
Continuation awards within the project period will be made on the
basis of satisfactory progress as evidenced by required reports and the
availability of funds.
D. Program Requirements
1. Design, implement, and conduct an extensive intervention program
to increase placement of children properly restrained in the back seat
of motor vehicles. The intervention program will be developed using a
sound theoretical basis in health behavior change.
2. Establish links and/or collaborative relationships with
interested partners in the intervention and two control communities,
especially representatives from local health departments, police,
academic institutions, and traffic safety and injury control
specialists.
3. Identify the targeted intervention community and the communities
which will serve as the ``control'' communities.
4. Establish a community coalition to provide direction and broad
penetration of the intervention.
5. Conduct an assessment of the project. The primary outcome
measure used to evaluate the intervention will be a change in the
proportion of children riding in back versus the front seat of
passenger cars and light trucks.
6. Conduct an analysis of the cost effectiveness of the community
intervention; carry out a detailed process evaluation in the
intervention community; and compile, publish, and disseminate results.
E. Application Content
The application should be developed in accordance with Form PHS-
398.
1. State briefly your understanding of the purpose of the program.
2. Describe in detail the process you will use to accomplish the
requirements of the program. This process description should include
specific planning objectives, strategies for achievement of these
objectives, and a proposed schedule for achieving these objectives.
Describe the population to be served and how participants will be
identified.
3. Describe your capability to conduct the proposed project,
including the applicant's experience in conducting and evaluating
projects similar to the proposed project.
4. Provide the name, qualifications, and proposed time allocations
of the Project Director, who will be responsible for administering the
grant. Describe requirements for additional staff, experience,
facilities, and other resources that would define the applicant's
capacity or potential to accomplish the requirements stated above. List
the names (if known), qualifications, and time allocations of the
existing professional staff to be assigned to (or recruited for) this
project.
5. Provide a detailed budget which indicates anticipated costs for
personnel, travel, communications, postage, equipment, contracts,
supplies, and other items; and all sources of funds to meet these
expenses.
6. The narrative should be no more than 25 double-spaced pages,
printed on one side, with one-inch margins, and unreduced font.
7. If human subjects will be involved in this research, provide
evidence of compliance with the Department of Health and Human Services
regulations (45 CFR part 46) on the protection of Human Subjects.
F. Submission and Deadline
Application
Submit one original and five copies of PHS 398 (OMB Number 0925-
0001) (adhere to the instructions on the Errata Instruction Sheet for
PHS 398). Forms are in the application kit. On or before July 15, 1999,
submit the application to the specialist identified in the ``Where to
Obtain Additional Information'' section of this announcement.
Deadline: Applications shall be considered as meeting the deadline
if they are either:
(a) Received on or before the deadline date; or
(b) Sent on or before the deadline date and received in time for
orderly processing. (Applicants must request a legibly dated U.S.
Postal Service postmark or obtain a legibly dated receipt from a
commercial carrier or U.S. Postal Service. Private metered postmarks
shall not be acceptable as proof of timely mailing.)
Late Applications: Applications which do not meet the criteria in
(a) or (b) above are considered late applications, will not be
considered, and will be returned to the applicant.
G. Evaluation Criteria
Each application will be evaluated individually against the
following criteria by an independent review group appointed by CDC.
1. Background and Need (10 percent)
The extent to which the applicant presents the magnitude of the
need for this project, demonstrates experience in this area, and
describes the likely impact of their activities on the need.
2. Goals and Objectives (10 Percent)
The extent to which the goal(s) and objectives are relevant to the
purpose of the program, feasible for accomplishment during the project
period, measurable, and specific in terms of what is to be done and the
time involved. The extent to which the objectives address all
activities necessary to accomplish the purpose of the program.
3. Methods (30 Percent)
The extent to which the applicant provides a detailed description
of all proposed activities needed to achieve each objective and the
overall program goal(s). The extent to which the study collaborators
have demonstrated expertise in conducting community interventions. The
extent to which the applicant has experience and history of publication
on motor vehicle occupant protection. The extent to which the applicant
provides a reasonable and complete schedule for implementing all
activities. The extent to which position descriptions, lines of
command, and collaborations are appropriate to accomplishing the
program goal(s) and objectives.
The degree to which the applicant has met the CDC Policy
requirements regarding the inclusion of women, ethnic, and racial
groups in the proposed research. This includes: (a) the proposed plan
for the inclusion of both sexes and racial and ethnic minority
populations for appropriate representation, (b) the proposed
justification when representation is limited or absent, (c) a statement
as to whether the design of the study is
[[Page 26761]]
adequate to measure differences when warranted, and (d) a statement as
to whether the plans for recruitment and outreach for study
participants include the process of establishing collaborative
relationships with community(ies) and recognition of mutual benefits.
4. Evaluation (30 Percent)
The extent to which the proposed evaluation plan is detailed and
capable of documenting program process and outcome measures, including
benefit/cost analysis, risk assessment, and risk management (applicants
may wish to refer to A Framework for Assessing the Effectiveness of
Disease and Injury Prevention, MMWR, March 27, 1992/Vol.41/No. RR-3 for
further information on this methodology). You may access this document
on CDC's Web page at www2.cdc.gov/mmwr/mmwrsrch.htm. The extent to
which the applicant demonstrates staff and/or collaborator
availability, expertise, and capacity to perform the evaluation.
5. Staff, and Resources (20 Percent)
Providing for a full-time director/coordinator and staff who have
authority, responsibility, and expertise to carry out the project. The
extent to which the applicant can provide adequate facilities, staff
and/or collaborators, and resources to accomplish the proposed goal(s)
and objectives during the project period. The extent to which the
applicant demonstrates staff and/or collaborator availability,
expertise, previous experience, broad experience in risk assessment and
analysis and capacity to perform the undertaking successfully.
6. Budget and Justification (Not Scored)
The extent to which the applicant provides a detailed budget and
narrative justification consistent with the stated objectives and
planned program activities.
7. Human Subjects (Not Scored)
Does the application adequately address the requirements of Title
45 CFR Part 46 for the protection of human subjects?
H. Other Requirements
Technical Reporting Requirements
Provide CDC with original plus two copies of:
1. semiannual progress reports
2. financial status report, no more than 90 days after the end of the
budget period; and
3. final financial and performance reports, no more than 90 days after
the end of the project period.
Send all reports to the Grants Management Specialist identified in
the ``Where to Obtain Additional Information'' section of this
announcement.
The following additional requirements are applicable to this
program. For a complete description of each, see Addendum I.
AR-1 Human Subjects Requirements
AR-2 Requirements for Inclusion of Women and Racial and Ethnic
Minorities in Research
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2000
AR-12 Lobbying Restrictions
AR-13 Prohibition on Use of CDC Funds for Certain Gun Control
Activities
I. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under sections 301, 317(k)(2), 391, 392,
and 394 of the Public Health Service Act, [42 U.S.C. section 241,
247b(k)(2), 280b, 280b-1, and 280b-2], as amended. The Catalog of
Federal Domestic Assistance number is 93.136.
J. Where To Obtain Additional Information
This and other CDC announcements may be downloaded through the CDC
home page www.cdc.gov on the Internet (click on funding).
To receive additional written information and to request an
application kit, call 1-888-GRANTS4 (1-888 472-6874). You will be asked
to leave your name and address and will be instructed to identify the
Announcement number of interest.
For business management technical assistance, contact: Joanne
Wojcik, Grants Management Specialist, Grants Management Branch,
Procurement and Grants Office, Announcement 99123, Centers for Disease
Control and Prevention (CDC), 2920 Brandywine Road, Room 3000, Atlanta,
GA 30341-4146, telephone (770) 488-2717, Email address: jcw6@cdc.gov
For program technical assistance, contact: Bruce Jones, M.D.,
Centers for Disease Control and Prevention, National Center for Injury
Prevention and Control, Division of Unintentional Injury Prevention,
4770 Buford Hwy., N.E., Mailstop K63, Atlanta, GA 30341-3724,
telephone: 770 488-4545, email address: bdj2@cdc.gov
Dated: May 11, 1999.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 99-12312 Filed 5-14-99; 8:45 am]
BILLING CODE 4163-18-P
